Literature DB >> 18360307

Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone.

Anja Overdiek1, Ursula Winner, Ertan Mayatepek, Thorsten Rosenbaum.   

Abstract

Neurofibromatosis type 1 (NF1) is a hereditary disease caused by mutations of the NF1 gene at 17q11.2. Loss of the NF1 gene product in Schwann cells leads to the development of benign nerve sheath tumors. These neurofibromas may occur at any time but tend to arise during periods of hormonal imbalance, suggesting that hormones influence neurofibroma growth. As steroid hormone levels rise during these times, we hypothesized that progesterone has proliferative effects on neurofibroma-derived Schwann cells. We chose specific medium conditions for selective proliferation of NF (+/-) and NF (-/-) cells from human neurofibromas. Genetic characterization was not performed, but former works have shown that under the conditions used (+/-) and (-/-) cells can be selected. Different progesterone concentrations were added at different days with BrdU-staining was performed to investigate proliferation rates and DAB-staining to identify a progesterone receptor. We could demonstrate that Schwann cells from human neurofibromas express progesterone receptors. These cells show elevated proliferation rates (highest in NF(-/-) cells) under progesterone, whereas normal human Schwann cells were not affected. These data suggest that progesterone plays an important role in the development of neurofibromas in NF1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360307     DOI: 10.1203/PDR.0b013e31817445b8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

2.  The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.

Authors:  Paula Pennanen; Sirkku Peltonen; Roope A Kallionpää; Juha Peltonen
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

Review 3.  Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.

Authors:  Justin Korfhage; David B Lombard
Journal:  Mol Cancer Res       Date:  2019-04-25       Impact factor: 5.852

4.  Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.

Authors:  Hua Li; Xuelian Zhang; Lauren Fishbein; Frederick Kweh; Martha Campbell-Thompson; George Q Perrin; David Muir; Margaret Wallace
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

5.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

6.  Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.

Authors:  Tu Anh Duong; Emilie Sbidian; Laurence Valeyrie-Allanore; Cédric Vialette; Salah Ferkal; Smaïl Hadj-Rabia; Christophe Glorion; Stanislas Lyonnet; Michel Zerah; Isabelle Kemlin; Diana Rodriguez; Sylvie Bastuji-Garin; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2011-05-04       Impact factor: 4.123

7.  Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1.

Authors:  Rafaela E Rozza-de-Menezes; Nicolle C Gaglionone; Raquel M Andrade-Losso; Orlando H K Siqueira; Lilian M Almeida; Kamila da S Peruzini; Marco A C Guimarães-Filho; Carolina I Brum; Mauro Geller; Karin S Cunha
Journal:  Orphanet J Rare Dis       Date:  2017-12-20       Impact factor: 4.123

8.  Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study.

Authors:  Emilie Sbidian; Smaïl Hadj-Rabia; Vincent M Riccardi; Laurence L Valeyrie-Allanore; Sébastien Barbarot; Olivier Chosidow; Salah Ferkal; Diana Rodriguez; Pierre Wolkenstein; Sylvie Bastuji-Garin
Journal:  Orphanet J Rare Dis       Date:  2012-09-03       Impact factor: 4.123

9.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

Review 10.  Cutaneous neurofibromas in the genomics era: current understanding and open questions.

Authors:  Robert J Allaway; Sara J C Gosline; Salvatore La Rosa; Pamela Knight; Annette Bakker; Justin Guinney; Lu Q Le
Journal:  Br J Cancer       Date:  2018-04-26       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.